PMC:7784830 / 2707-2872 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"48","span":{"begin":68,"end":78},"obj":"Chemical"},{"id":"49","span":{"begin":80,"end":99},"obj":"Chemical"}],"attributes":[{"id":"A48","pred":"tao:has_database_id","subj":"48","obj":"MESH:C000606551"},{"id":"A49","pred":"tao:has_database_id","subj":"49","obj":"MESH:C558899"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"World Health Organization (WHO) identified and recommended usage of remdesivir, lopinavir–ritonavir with or without interferon, immunotherapy, and recuperative sera."}

{"project":"LitCovid-sentences","denotations":[{"id":"T30","span":{"begin":0,"end":165},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"World Health Organization (WHO) identified and recommended usage of remdesivir, lopinavir–ritonavir with or without interferon, immunotherapy, and recuperative sera."}